Products

18:1 Cyclic LPA | 857328

1-oleoyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt)

857328P

500 µg Powder

1 ea
$87.00

1000 µg Powder

1 ea
$157.00

All Prices in US Dollars
This product Is pre-packaged in the unit sizes indicated above.
Quantity discounts are available at the 5 and 10 count level.
Add your chosen unit to the shopping cart and adjust the quantity to see the discount.


To purchase larger quantities of this product please contact our Customer Service Department

  • Product
  • Data
  • Downloads
  • Reference
Cyclic phosphatidic acid (cPA) is a naturally occurring analog of the growth factor-like phospholipid mediator, lysophosphatidic acid (LPA). The sn-2 hydroxy group of CPA forms a 5-membered ring with the sn-3 phosphate. cPA affects numerous cellular functions, including anti-mitogenic regulation of the cell cycle1, induction of stress fiber formation2, inhibition of tumor cell invasion and metastasis3, and regulation of differentiation and survival of neuronal cells4. Interestingly, many of these cellular responses caused by cPA oppose those of LPA despite the activation of apparently overlapping receptor populations.
You can find additional information on cPA at the following link: LIPID MAPS Lipidomics Gateway
1. Murakami-Murofushi, K., Kaji, K., Kano, K., Fukuda, M., Shioda, M., and Murofushi, H. (1993) Inhibition of cell proliferation by a unique lysophosphatidic acid, PHYLPA, isolated from Physarum polycephalum: signaling events of antiproliferative action by PHYLPA. Cell Struct. Funct. 18:363–370.
2. Fischer, D.L., Liliom, K., Guo, H., Nusser, N., Virag, T., Murakami-Murofushi, K., Kobayashi, S., Erickson, J.P., Sun, G., Miller, D.D., and Tigyi, G. (1998) Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes. Mol. Pharmacol. 54:979–988.
3. Mukai, M., Imamura, F., Ayaki, M., Shinkai, K., Iwasaki, T., Murakami-Murofushi, K., Murofushi, H., Kobayashi, S., Yamamoto, T., Nakamura, H., and Akedo, H. (1999) Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA). Int. J. Cancer 81:918–922.
4. Fujiwara, Y., Sebok, A., Meakin, S., Kobayashi, T., Murakami-Murofushi, K., and Tigyi, G. (2003) Cyclic phosphatidic acid elicits neurotrophin-like actions in embryonic hippocampal neurons. J. Neurochem. 87:1272–1283.
Molecular Formula
C21H42NO6P
Percent Composition
C 57.91%, H 9.72%, N 3.22%, O 22.04%, P 7.11%
Purity
>99%
Stability
1 Year
Storage
-20°C
CAS Number
799268-72-7
CAS Registry Number is a Registered Trademark of the American Chemical Society
Molecular Weight
435.535
Exact Mass
435.275
Synonyms
1-(9Z-octadecenoyl)-sn-glycero-2,3-cyclic-phosphate (ammonium salt)
Download
Notes
GIF Graphics File. 
GIF Graphics File. 
MDL Molfile. 
CDX File. 
Fujiwara Y. (2008) Cyclic phosphatidic acid - a unique bioactive phospholipid. Biochim Biophys Acta. 1781:519-24. [PubMed] Murakami-Murofushi, K., Kaji, K., Kano, K., Fukuda, M., Shioda, M., and Murofushi, H. (1993) Inhibition of cell proliferation by a unique lysophosphatidic acid, PHYLPA, isolated from Physarum polycephalum: signaling events of antiproliferative action by PHYLPA. Cell Struct. Funct. 18:363–370. [PubMed] Fischer, D.L., Liliom, K., Guo, H., Nusser, N., Virag, T., Murakami-Murofushi, K., Kobayashi, S., Erickson, J.P., Sun, G., Miller, D.D., and Tigyi, G. (1998) Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.Mol. Pharmacol. 54:979–988. [PubMed] Mukai, M., Imamura, F., Ayaki, M., Shinkai, K., Iwasaki, T., Murakami-Murofushi, K., Murofushi, H., Kobayashi, S., Yamamoto, T., Nakamura, H., and Akedo, H. (1999) Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA). Int. J. Cancer 81:918–922. [PubMed] Fujiwara, Y., Sebok, A., Meakin, S., Kobayashi, T., Murakami-Murofushi, K., and Tigyi, G. (2003) Cyclic phosphatidic acid elicits neurotrophin-like actions in embryonic hippocampal neurons. J. Neurochem. 87:1272–1283. [PubMed]